Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Theravance Biopharma, Inc. | SVP, CHIEF BUSINESS OFFICER | Ordinary Shares | 430K | $4.42M | $10.29 | Nov 19, 2021 | Direct |
Enveric Biosciences, Inc. | Director | Common Stock | 48.7K | Oct 9, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ENVB | Enveric Biosciences, Inc. | Oct 9, 2024 | 1 | $0 | 4 | Oct 11, 2024 | Director |
ENVB | Enveric Biosciences, Inc. | Sep 15, 2023 | 1 | $2.14K | 4 | Sep 19, 2023 | Director |
ENVB | Enveric Biosciences, Inc. | Jul 13, 2022 | 0 | $0 | 3 | Jul 22, 2022 | Director |
TBPH | Theravance Biopharma, Inc. | Nov 19, 2021 | 1 | -$31.6K | 4 | Nov 23, 2021 | SVP, CHIEF BUSINESS OFFICER |
TBPH | Theravance Biopharma, Inc. | Aug 20, 2021 | 1 | -$53.1K | 4 | Aug 24, 2021 | SVP, Chief Business Officer |
TBPH | Theravance Biopharma, Inc. | May 20, 2021 | 1 | -$67.3K | 4 | May 24, 2021 | SVP, Chief Business Officer |